Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin.
A. fumigatus
CrzA
caspofungin
transcriptome
Journal
Genetics
ISSN: 1943-2631
Titre abrégé: Genetics
Pays: United States
ID NLM: 0374636
Informations de publication
Date de publication:
04 01 2022
04 01 2022
Historique:
accepted:
07
10
2021
received:
27
08
2021
pubmed:
1
11
2021
medline:
24
3
2022
entrez:
31
10
2021
Statut:
ppublish
Résumé
Aspergillus fumigatus is the main causative agent of invasive pulmonary aspergillosis (IPA), a severe disease that affects immunosuppressed patients worldwide. The fungistatic drug caspofungin (CSP) is the second line of therapy against IPA but has increasingly been used against clinical strains that are resistant to azoles, the first line antifungal therapy. In high concentrations, CSP induces a tolerance phenotype with partial reestablishment of fungal growth called CSP paradoxical effect (CPE), resulting from a change in the composition of the cell wall. An increasing number of studies has shown that different isolates of A. fumigatus exhibit phenotypic heterogeneity, including heterogeneity in their CPE response. To gain insights into the underlying molecular mechanisms of CPE response heterogeneity, we analyzed the transcriptomes of two A. fumigatus reference strains, Af293 and CEA17, exposed to low and high CSP concentrations. We found that there is a core transcriptional response that involves genes related to cell wall remodeling processes, mitochondrial function, transmembrane transport, and amino acid and ergosterol metabolism, and a variable response related to secondary metabolite (SM) biosynthesis and iron homeostasis. Specifically, we show here that the overexpression of a SM pathway that works as an iron chelator extinguishes the CPE in both backgrounds, whereas iron depletion is detrimental for the CPE in Af293 but not in CEA17. We next investigated the function of the transcription factor CrzA, whose deletion was previously shown to result in heterogeneity in the CPE response of the Af293 and CEA17 strains. We found that CrzA constitutively binds to and modulates the expression of several genes related to processes involved in CSP tolerance and that crzA deletion differentially impacts the SM production and growth of Af293 and CEA17. As opposed to the ΔcrzACEA17 mutant, the ΔcrzAAf293 mutant fails to activate cell wall remodeling genes upon CSP exposure, which most likely severely affects its macrostructure and extinguishes its CPE. This study describes how heterogeneity in the response to an antifungal agent between A. fumigatus strains stems from heterogeneity in the function of a transcription factor and its downstream target genes.
Identifiants
pubmed: 34718550
pii: 6414621
doi: 10.1093/genetics/iyab183
pmc: PMC8733440
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI153356
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118885
pubmed: 33045305
Med Mycol. 2021 Jan 4;59(1):7-13
pubmed: 32944768
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):E497-504
pubmed: 22106303
PLoS Genet. 2008 Apr 11;4(4):e1000046
pubmed: 18404212
Biotechnol Adv. 2019 Nov 1;37(6):107345
pubmed: 30738111
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28848005
Mycopathologia. 2014 Dec;178(5-6):341-8
pubmed: 25118871
PLoS Pathog. 2020 Jul 15;16(7):e1008645
pubmed: 32667960
Infect Immun. 2017 Nov 17;85(12):
pubmed: 28947643
PLoS Pathog. 2019 May 22;15(5):e1007787
pubmed: 31116789
Microbiology (Reading). 2014 Apr;160(Pt 4):742-751
pubmed: 24464798
Bioinformatics. 2011 Jun 15;27(12):1696-7
pubmed: 21486936
Mol Microbiol. 2011 Oct;82(1):39-53
pubmed: 21883519
Stud Mycol. 2007;59:11-7
pubmed: 18490942
Bioinformatics. 2011 Apr 1;27(7):1017-8
pubmed: 21330290
Ann N Y Acad Sci. 2015 Sep;1354:1-11
pubmed: 26190298
G3 (Bethesda). 2016 Sep 08;6(9):2983-3002
pubmed: 27473315
PLoS Biol. 2017 Nov 17;15(11):e2003583
pubmed: 29149178
FEMS Microbiol Rev. 2015 Sep;39(5):670-87
pubmed: 25934117
Med Mycol. 2017 Jan 1;55(1):82-86
pubmed: 27915304
Ann Allergy Asthma Immunol. 2018 Aug;121(2):200-210.e2
pubmed: 29660515
mSphere. 2016 Oct 26;1(5):
pubmed: 27830189
PLoS One. 2017 Apr 28;12(4):e0176702
pubmed: 28453536
Mol Microbiol. 2008 Mar;67(6):1274-91
pubmed: 18298443
J Am Chem Soc. 2013 Feb 13;135(6):2064-7
pubmed: 23360537
Antimicrob Agents Chemother. 2015 Mar;59(3):1738-44
pubmed: 25583716
Fungal Genet Biol. 2009 Sep;46(9):707-13
pubmed: 19460452
Rev Iberoam Micol. 2010 Oct-Dec;27(4):155-82
pubmed: 20974273
Biotechnol Biofuels. 2015 Dec 18;8:213
pubmed: 26690721
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31061164
PLoS One. 2015 Aug 21;10(8):e0135195
pubmed: 26295576
Antimicrob Agents Chemother. 1999 Aug;43(8):1856-61
pubmed: 10428902
Infect Dis Clin North Am. 2017 Sep;31(3):475-487
pubmed: 28687215
PLoS Pathog. 2010 Jun 10;6(6):e1000952
pubmed: 20548963
Front Microbiol. 2014 Oct 24;5:530
pubmed: 25386169
Antimicrob Agents Chemother. 2013 Oct;57(10):5127-30
pubmed: 23836187
mBio. 2020 Jun 16;11(3):
pubmed: 32546620
Genetics. 2011 Dec;189(4):1145-75
pubmed: 22174182
Int J Mol Sci. 2019 Jul 17;20(14):
pubmed: 31319476
Nature. 2005 Dec 22;438(7071):1151-6
pubmed: 16372009
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i39-i47
pubmed: 28355466
Appl Environ Microbiol. 2020 Mar 18;86(7):
pubmed: 32005734
Sci Rep. 2020 Feb 11;10(1):2362
pubmed: 32047210
Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5
pubmed: 9564455
Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709):
pubmed: 28080993
mBio. 2016 Sep 20;7(5):
pubmed: 27651362
J Fungi (Basel). 2018 Feb 02;4(1):
pubmed: 29393895
Adv Genet. 1977;19:33-131
pubmed: 327767
Mycologia. 2007 Nov-Dec;99(6):804-11
pubmed: 18333504
Mol Microbiol. 2012 Jun;84(5):942-64
pubmed: 22500966
Antimicrob Agents Chemother. 2011 Jan;55(1):146-54
pubmed: 20974863
Mol Microbiol. 2016 Oct;102(2):321-335
pubmed: 27393422
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
BMC Syst Biol. 2018 Oct 20;12(1):88
pubmed: 30342519
mBio. 2017 Jun 13;8(3):
pubmed: 28611248
Genome Biol. 2019 Nov 14;20(1):238
pubmed: 31727128
Nat Rev Microbiol. 2018 Dec;16(12):731-744
pubmed: 30194403
Nat Biotechnol. 2016 Aug 9;34(8):828-837
pubmed: 27504778
Microbiol Spectr. 2021 Sep 3;9(1):e0001021
pubmed: 34106569
J Biol Chem. 2002 Aug 23;277(34):31079-88
pubmed: 12058033
mSphere. 2020 Jun 24;5(3):
pubmed: 32581072
Crit Care. 2015 Jan 12;19:7
pubmed: 25928694
PLoS Pathog. 2007 Sep 28;3(9):1195-207
pubmed: 17845073
Environ Microbiol. 2016 Jan;18(1):246-59
pubmed: 26242966
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28760907
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Cell Commun Signal. 2020 Jan 3;18(1):1
pubmed: 31900175
PLoS Pathog. 2018 Aug 2;14(8):e1007229
pubmed: 30071103
Infect Immun. 1997 Aug;65(8):3171-9
pubmed: 9234771
Front Microbiol. 2015 Jan 05;5:732
pubmed: 25601857
Appl Microbiol Biotechnol. 2010 Jul;87(3):899-911
pubmed: 20495914
Nat Prod Rep. 2014 Oct;31(10):1266-76
pubmed: 25140791
Appl Environ Microbiol. 2013 Nov;79(21):6670-6
pubmed: 23974138
Front Microbiol. 2015 Apr 16;6:325
pubmed: 25932027
PLoS Genet. 2019 Dec 30;15(12):e1008551
pubmed: 31887136
mBio. 2017 Feb 21;8(1):
pubmed: 28223452
mBio. 2016 Sep 20;7(5):
pubmed: 27651366
Antimicrob Agents Chemother. 2004 Sep;48(9):3407-11
pubmed: 15328104
Metallomics. 2012 Dec;4(12):1262-70
pubmed: 23151814
ACS Cent Sci. 2020 Oct 28;6(10):1698-1712
pubmed: 33145409
mBio. 2019 Jun 4;10(3):
pubmed: 31164462
Genetics. 2020 Oct;216(2):481-497
pubmed: 32817009
Front Microbiol. 2019 Apr 24;10:854
pubmed: 31105662
Antimicrob Agents Chemother. 2001 Jan;45(1):52-9
pubmed: 11120944
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
Pathogens. 2015 Dec 16;4(4):883-93
pubmed: 26694470
Eukaryot Cell. 2006 Feb;5(2):411-21
pubmed: 16467481
Front Genet. 2020 May 12;11:459
pubmed: 32477406
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
mSphere. 2018 Mar 14;3(2):
pubmed: 29564395
Clin Biochem. 2007 Jun;40(9-10):575-84
pubmed: 17467679
Proc (Bayl Univ Med Cent). 2002 Jan;15(1):97-9
pubmed: 16333416
Antimicrob Agents Chemother. 2010 Apr;54(4):1555-63
pubmed: 20124000